Anbioton has been acquired by Elfa Medicamentos
The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.
Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.
Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.
One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.
Talk to the deal team
Related deals
Thrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH
Paradiesfrucht GmbH, a gobal freeze dryer of fruits, fruit preparations, drops, powders and granulates, has been acquired by Thrive Freeze Dry (Thrive), a portfolio company of Entrepreneurial Equity Partners (e2p) and Mubadala Capital. The transaction is expected to close in 2024, subject to customary closing conditions, including antitrust approval.
Learn morePerkbox has been acquired by Great Hill Partners
Molten Ventures has sold Perkbox to Great Hill Partners.
Learn moreArculus Cyber Security has been acquired by Bridewell
The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.
Learn more